FluoroPharma Medical (FluoroPharma Medical) EV-to-EBIT : -0.01 (As of Apr. 26, 2024)

FluoroPharma Medical EV-to-EBIT Chart

FluoroPharma Medical Annual Data
	Trend	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16
EV-to-EBIT		Get a 7-Day Free Trial					-4.58	-2.64	-3.36	-6.09	-12.15

FluoroPharma Medical Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16
EV-to-EBIT	Get a 7-Day Free Trial															-6.09	-4.49	-6.70	-7.11	-12.15

Competitive Comparison of FluoroPharma Medical's EV-to-EBIT

For the Biotechnology subindustry, FluoroPharma Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FluoroPharma Medical's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FluoroPharma Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where FluoroPharma Medical's EV-to-EBIT falls into.

FluoroPharma Medical EV-to-EBIT Calculation

FluoroPharma Medical's EV-to-EBIT for today is calculated as:

FluoroPharma Medical's current Enterprise Value is $0.00 Mil.
FluoroPharma Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FluoroPharma Medical  (OTCPK:FPMI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

FluoroPharma Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2016 is calculated as:

FluoroPharma Medical's Enterprise Value for the quarter that ended in Dec. 2016 was $9.55 Mil.
FluoroPharma Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FluoroPharma Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of FluoroPharma Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

FluoroPharma Medical (FluoroPharma Medical) Business Description